Apple claims its new watch could revolutionise the healthcare industry.
During an announcement yesterday, Apple announced several potentially life-saving additions to its Apple Watch lineup.
Apple claims its new watch comes with ‘revolutionary health capabilities’ which means it is able to detect falls and an electrical heart rate sensor that can take an electrocardiogram (ECG).
According to the US Food and Drug Administration (FDA) the ECG app will be able “determine the presence of atrial fibrillation (AFib) or sinus rhythm on a classifiable waveform” but warns it is “not recommended for users with other known arrhythmias” or to be used by those under 22 years of age.
To take an ECG reading with the Apple Watch, users will need to place a finger on the Digital Crown while wearing the watch. The reading is completed in just 30 seconds
ECG data gathered by Apple Watch Series 4 models is stored in the Health app in a PDF format that can easily be shared with healthcare professionals.
The FDA warns that the watch could potentially cause patients to not seek treatment despite acute symptoms or cause them to alter their own treatment based on the information provided by the watch.
Presently, the ECG feature of the watch has only been approved for use in the US so will not be available on watched purchased in the UK.
The fall-detection technology on the watch uses a built-in accelerometer and gyroscope to identify when falls occur.
When the Apple Watch detects a fall it will send the user an alert with an option call to emergency services. If the Apple Watch senses the wearer is immobile for 60 seconds after the notification, the watch can automatically call emergency services and send a message along with the wearers’ location to emergency contacts.
The new Apple Watch Series 4 will start at £399 and will be available to preorder from 14/09/2018.